WinfredFunding Intelligence

Back to Startups

SB

SOLASTA Bio

SOLASTA Bio develops green peptide-based insecticides for agricultural use.

United Kingdom—Founded 2020

$18.0MTotal raised

SOLASTA Bio develops nature-inspired peptide-based insecticides designed to protect crops while preserving pollinators.

Categories

Founders

SD

Shireen Davies

CEO

PB

Paul Bernasconi

Chief Technology Officer

Investors

Series A11 September 2024
$14.0M
F
ForbionLead
FV
FMC VenturesLead
C
CortevaLead
CV
Cavallo VenturesFollow-on
RI
Rubio Impact VenturesFollow-on
Scottish EnterpriseFollow-on
SIS VenturesFollow-on
Uo
University of Glasgow
Pre-Seed11 April 2023
£4.0M
YL
Yield Lab EuropeLead
RI
Rubio Impact Ventures
Scottish Enterprise
CV
Cavallo Ventures
SIS Ventures
UKI2S

Funding history

Series A11 September 2024

$14.0M

SOLASTA Bio secures $14m in Series A funding led by Forbion to scale green insecticide development.

The oversubscribed round was co-led by Forbion, FMC Ventures, and Corteva Inc.

Pre-Seed11 April 2023

£4.0M

SOLASTA Bio secures £4m pre-Series A funding led by Yield Lab Europe to scale eco-friendly insecticides.

Yield Lab Europe led the pre-Series A round, which will fund international expansion and team growth.